An evaluation of opioid use during acute hospital admissions

Long-term opioid use can begin with the treatment of acute pain. However, there is little evidence concerning the impact that better opioid awareness in the acute phase may have on reducing the use of opioids in the long term. This project explored which opioids are routinely prescribed within an acute hospital setting and how these opioids were used over the course of the hospital stay. Codeine and morphine remain the most commonly prescribed opioids. Opioids were prescribed and given to people across the age range, from 16 to 98 years. The project found that 19% of patients were admitted with a pre-existing opioid. Up to 66% of patients were discharged with opioid medication, with almost 20% leaving with more than one opioid. Regular opioid use routinely exposes patients to long-term opioid use and those patients initiated onto opioid medication during admission should have the benefit of planned de-escalation before discharge.

An evaluation of a virtual COVID-19 ward to accelerate the supported discharge of patients from an acute hospital setting:

Background/Aims In response to high numbers of hospital admissions as a result of COVID-19, a virtual ward was implemented to achieve accelerated discharge from hospital without compromising patient safety. This study assessed the impact of this virtual ward for patients admitted to the acute hospital setting with COVID-19. Methods A community-based intervention using digital technology and a multi-disciplinary team of specialist clinicians to monitor patients at home was established. An analysis was carried out within the service investigating the safety, health outcomes and resource use of the first 65 patients discharged from hospital into the virtual respiratory ward. Results Red days, where an urgent response was required, decreased from 33.8% of patients in their first 3 days at the virtual ward to 10.8% in their final 3 days (P=0.002). Four patients were readmitted to hospital, all for clotting disorders. There was one death, which was deemed unrelated to COVID-19. Length of stay was also reduced by 40.3% (P<0.001) and estimated overall savings were £68 052 (£1047 per patient). Conclusions The virtual ward appeared to assist with earlier discharges, had a low rate of clinically necessary re-admissions, and seemed to reduce costs without compromising patient safety. The authors believe that this intervention could be applied across other NHS trusts facing similar capacity issues as a result of COVID-19.

Evaluating the specialist palliative care clinical nurse specialist role in an acute hospital setting: a mixed methods sequential explanatory study

Background Special palliative care is provided in a range of settings including a patient’s home (their primary place of dwelling), a hospice in-patient unit, or an acute hospital. The aim of the study was to evaluate the role of the specialist in palliative care clinical nurse specialist (SPC CNS) role in an acute hospital setting. Methods This study was conducted using a mixed methods sequential explanatory approach in two phases; phase 1 involved completion of a study questionnaire (n = 121) and phase 2 involved part-taking in a focus group (n = 6) or individual interview (n = 4). Results Phase 1 results indicated that respondents held positive attitudes towards the Specialist Palliative Care Clinical Nurses Specialist (SPC CNS) in relation to clinical care, education and patient advocacy. Phase 2 qualitative findings identified the importance of the role in terms of symptom management, education and support. Conclusions This study provides an evaluation of a SPC CNS role since it was established in an acute hospital setting. The evidence indicates that there is a varied understanding of the role of the SPC CNS. The role was seen as an important one particularly in terms of referrals to and support provided by the SPC CNS, as well as recognition of the importance of the role is providing ongoing education to staff.